Find Clinical Trials | Cedars-Sinai

154 results found

Melanoma

Regeneron, R3767-ONC-2466, Ph2, open label, Melanoma, Fianlimab Plus Cemiplimab

Primary -Assess Overall Survival (OS) of patients with melanoma treated with Fianlimab Plus Cemiplimab in Expansion Cohorts from R3767-ONC-1613 Secondary -Assess Progression-Free Survival (PFS) -Assess Objective Response Rate (ORR) -Assess Duration of Response (DOR) -Assess Disease Control Rate (DCR) ...

Lung

Lung-MAP Non-Matched Sub-Study

This study focuses on people who have advanced non-small cell lung cancer (NSCLC) and who had previous treatment using chemotherapy that contains platinum and immunotherapy. The study is part of Lung-MAP, a large research project ...

Melanoma, Unknown Sites

SWOG, S2101, PhII, open label, Cabozantinib + Nivolumab, Melanoma or HNSCC

Primary Objective: 1. To evaluate the feasibility of molecular characterization based on tumor mutation burden (TMB) for participant stratification, as assessed by the proportion of participants with less than or equal to a 21-day ...

Breast

Tart Cherry and Omega-3 s for Aromatase Inhibitor Musculoskeletal Symptoms

This study focuses on people with breast cancer who have aromatase therapy-associated musculoskeletal symptoms. The purpose of the study is to determine whether tart cherry concentrate and fish oil, when taken together, have an impact ...

Melanoma

Cemiplimab plus Ziv-Aflibercept in Metastatic Uveal Melanoma

The purpose of this phase II study for advanced melanoma is to evaluate the safety (side effects profile) and effectiveness (tumor shrinkage) of cemiplimab and ziv-aflibercept, when given together. Cemiplimab is an anti-cancer drug called ...